Bromperidol
NERVOUS SYSTEM
Also known as: azurene, bromoperidol, bromperidol HCl, bromperidol hydrochloride, impromen, tesoprel
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Bromperidol is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1973. DrugCentral lists 12 molecular targets, including SIGMAR1, DRD2 and DRD4.
- Molecular targets: SIGMAR1, DRD2, DRD4 and DRD3 (12 listed in DrugCentral).
- ATC code: N05AD06 (Butyrophenone derivatives).
- Molecular formula: C21H23BrFNO2; molecular weight 420.32 g/mol.
Mechanism & targets
Molecular targets (12)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Sigma non-opioid intracellular receptor 1 | SIGMAR1 | unknown | EC50 9.02 |
| D(2) dopamine receptor | DRD2 | antagonist | Ki 8.43 |
| D(4) dopamine receptor | DRD4 | unknown | Ki 7.80 |
| D(3) dopamine receptor | DRD3 | unknown | Ki 7.50 |
| Alpha-1A adrenergic receptor | ADRA1A | unknown | Ki 7.10 |
| D(1A) dopamine receptor | DRD1 | unknown | Ki 7.00 |
| Histamine H1 receptor | HRH1 | unknown | Ki 6.16 |
| Muscarinic acetylcholine receptor M4 | CHRM4 | unknown | Ki 5.77 |
| Muscarinic acetylcholine receptor M2 | CHRM2 | unknown | Ki 5.75 |
| Muscarinic acetylcholine receptor M5 | CHRM5 | unknown | Ki 5.32 |
| Muscarinic acetylcholine receptor M3 | CHRM3 | unknown | Ki 5.15 |
| Muscarinic acetylcholine receptor M1 | CHRM1 | unknown | Ki 5.12 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1973-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N05AD06 | NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Butyrophenone derivatives |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Bromperidol is on its molecule page.
| Molecular formula | C21H23BrFNO2 |
|---|---|
| Molecular weight | 420.32 g/mol |
| CAS number | 10457-90-6 |
| InChIKey | RKLNONIVDFXQRX-UHFFFAOYSA-N |
| PubChem CID | 2448 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Bromperidol work?
Its molecular targets in DrugCentral include SIGMAR1, DRD2 (antagonist), DRD4 and DRD3.
When was Bromperidol first approved?
Bromperidol was first approved by the YEAR INTRODUCED in 1973.
What is the chemical formula of Bromperidol?
Bromperidol has the molecular formula C21H23BrFNO2 and a molecular weight of 420.32 g/mol.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 407 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL28218 — compound record and bioactivity
- PubChem CID 2448 — chemical identifiers
- DrugBank DB12401 — drug record
- FDA UNII LYH6F7I22E — substance identity
- UniProt Q99720 (SIGMAR1) — target protein
- UniProt P14416 (DRD2) — target protein
- UniProt P21917 (DRD4) — target protein
- UniProt P35462 (DRD3) — target protein
- UniProt P35348 (ADRA1A) — target protein
- UniProt P21728 (DRD1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.